Abstract
Indoor fungal contamination is associated with a wide range of adverse health effects, including infectious diseases, allergies and toxic effects. Various indoor environments are concerned by fungal health risk, particularly hospitals and critical care environments where immunosuppressed patients are hosted. Prevention of nosocomial invasive fungal infections in health-care facilities is mainly based on air treatment with monitoring environmental fungal contamination and epidemiological follow-up of invasive fungal infections. After reminding the reservoir of fungi at hospitals and the routes of transmission, we review what measures of fungal risk control should be implemented and tools that are relevant for an efficient environmental monitoring.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alberti C, Bouakline A, Ribaud P et al (2001) Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in hematology patients. J Hosp Infect 48:198–206
Anonymous Canada (2001) Canadian Communicable Disease Report. Construction-related nosocomial infections in patients in health care facilities. Volume 27S2, July 2001. http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/01vol27/27s2/index.html
Anonymous Ireland (2001) National Disease Surveillance Centre Ireland. National guidelines for the prevention of nosocomial invasive aspergillosis during construction/renovation activities. http://www.ndsc.ie/hpsc/A-Z/Respiratory/Aspergillosis/Guidance/File,896,en.pdf. 2001
Arnow PM, Sadigh M, Costas C et al (1991) Endemic and epidemic aspergillosis associated with in-hospital réplication of Aspergillus organisms. J Infect Dis 164:998–1002
Araujo R, Carneiro A, Costa-Oliveira S et al (2008) Fungal infections after haematology unit renovation: evidence of clinical environmental and economical impact. Eur J Haematol 80:436–443
Asmundsdóttir LR, Erlendsdóttir H, Haraldsson G et al (2008) Molecular epidemiology of candidemia: evidence of clusters of smoldering nosocomial infections. Clin Infect Dis 47:e17–24
Anaissie EJ, Stratton SL, Dignani MC et al (2003) Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. Blood 101:2542–2546
Barreiros G, Akiti T, Magalhães AC et al (2015) Effect of the implosion and demolition of a hospital building on the concentration of fungi in the air. Mycoses 58(12):707–13
Bénet T, Nicolle MC, Thiebaut A et al (2007) Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis 45:682–686
Bergeron V, Reboux G, Poirot JL et al (2007) Decreasing airborne contamination levels in high-risk hospital areas using a novel mobile air-treatment unit. Infect Control Hosp Epidemiol 28:1181–1186
Bouakline A, Lacroix C, Roux N et al (2000) Fungal contamination of food in hematology units. J Clin Microbiol 38:4272–4273
Brillowska-Dabrowska A, Schön T, Pannanusorn S et al (2009) A nosocomial outbreak of Candida parapsilosis in southern Sweden verified by genotyping. Scand J Infect Dis 41:135–142
Centers for Disease Control and Prevention (CDC) (1997) CDC guidelines for prevention of nosocomial pneumonia. MMWR 39:1192–1236
Chang CC, Ananda-Rajah M, Belcastro A et al (2014) Consensus guidelines for implementation of quality processes to prevent invasive fungal disease and enhanced surveillance measures during hospital building works, 2014. Intern Med J 44(12b):1389–97
Cheng VC, Chan JF, Ngan AH et al (2009) Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol 47:2834–2843
Cornet M, Levy V, Fleury L et al (1999) Efficacy of prevention by high-efficiency particulaite air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation. Infect Control Hosp Epidemiol 20:508–513
Cornillet A, Camus C, Nimubona S et al (2006) Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 43:577–584
Davoudi S, Graviss LS, Kontoyiannis DP (2015) Healthcare-associated outbreaks due to Mucorales and other uncommon fungi. Eur J Clin Invest 45(7):767–73
De Bock R, Gyssens I, Peetermans M et al (1989) Aspergillus in pepper. Lancet 2:331–332
Eckmanns T, Rüden H, Gastmeier P (2006) The influence of high-efficiency particulate air filtration on mortality and fungal infection among highly immunosuppressed patients: a systematic review. J Infect Dis 193:1408–1418
Fernandez-Gerlinger MP, Jannot AS, Rigaudeau S et al (2016) The plasmair decontamination system is protective against invasive Aspergillosis in neutropenic patients. Infect Control Hosp Epidemiol 37(7):845–51
French Consensus Conference (2000) [Prevention of invasive aspergillosis in immunosuppressed at risk population]. Hygiènes VII(6)
Gangneux JP, Bretagne S, Cordonnier C et al (2002) Prevention of nosocomial fungal infection: the French approach. Clin Infect Dis 35:343–345
Gangneux JP, Noussair L, Bouakline A (2004) Experimental assessment of disinfection procedures for eradication of Aspergillus fumigatus in food. Blood 104:2000–2002
Gangneux JP, Robert-Gangneux F, Gicquel G et al (2006) Bacterial and fungal counts in hospital air: comparative yields for 4 sieve impactor air samplers with 2 culture media. Infect Control Hosp Epidemiol 27:1405–1408
Haiduven D (2009) Nosocomial aspergillosis and building construction. Med Mycol 47(Suppl 1):S210–6
Kazan E, Maertens J, Herbrecht R et al (2011) A retrospective series of gut aspergillosis in haematology patients. Clin Microbiol Infect 17:588–594
Landrin A, Bissery A, Kac G (2005) Monitoring air sampling in operating theatres: can particle counting replace microbiological sampling? J Hosp Infect 61:27–9
Latgé JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:310–350
Lequilliec N, Raymond R, Vanjak D, Baghdadi N, Boulestreau H, Zahar JR, Gangneux JP, (2017) Practices of infectious control management during neutropenia: A survey from 149 French hospitals. Journal de Mycologie Médicale / Journal of Medical Mycology 27 (2):227–231
Loo VG, Bertrand C, Dixon C et al (1996) Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit. Infect Control Hosp Epidemiol 17:360–364
Lortholary O, Gangneux JP, Sitbon K et al (2011) Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007). Clin Microbiol Infect 17:1882–1889
Mahieu LM, De Dooy JJ, Van Laer FA et al (2000) A prospective study on factors influencing Aspergillus spore load in the air during renovation works in a neonatal intensive care unit. J Hosp Infect 45:191–197
Méheust D, Gangneux JP, Cann PL (2013) Comparative evaluation of three impactor samplers for measuring airborne bacteria and fungi concentrations. J Occup Environ Hyg 10(8):455–9
Méheust D, Le Cann P, Reboux G et al (2014) Indoor fungal contamination: health risks and measurement methods in hospitals, homes and workplaces. Crit Rev Microbiol 40(3):248–60
Patterson TF, Thompson 3rd GR, Denning DW et al (2016) Practice guidelines for the diagnosis and management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 63(4):e1–e60
Perfect JR, Hachem R, Wingard JR (2014) Update on epidemiology of and preventive strategies for invasive fungal infections in cancer patients. Clin Infect Dis 59(Suppl 5):S352–5
Piechno S, Seguin P, Gangneux JP (2007) Septiciémie due à Saccharomyces boulardii: attention aux levures. Can J Anaesth 54:245–246
Poirot JL, Gangneux JP, Fischer A et al (2007) Evaluation of a new mobile system for protecting immune-suppressed patients against airborne contamination. Am J Infect Control 35:460–466
Reboux G, Gbaguidi-Haore H, Bellanger AP et al (2014) A 10-year survey of fungal aerocontamination in hospital corridors: a reliable sentinel to predict fungal exposure risk? J Hosp Infect 87(1):34–40
Sautour M, Sixt N, Dalle F (2007) Prospective survey of indoor fungal contamination in hospital during a period of building construction. J Hosp Infect 67:367–373
SF2H-SFMM Working Group (2011) Risk of fungal infections and construction works in hospitals. Hygienes 19:1-52.
Sherertz RJ, Belani A, Kramer BS et al (1987) Impact of air filtration on nosocomial Aspergillus infections. Unique risk of bone marrow transplant recipients. Am J Med 83:709–718
Sixt N, Dalle F, Lafon I (2007) Reduced fungal contamination of the indoor environment with the Plasmair system (Airinspace). J Hosp Infect 65:156–162
Vermorel-Faure O, Lebeau B, Mallaret MR et al (1993) [Food-related fungal infection risk in agranulocytosis. Mycological control of 273 food items offered to patients hospitalized in sterile units]. Presse Med 22:157–160
Vonberg RP, Gastmeier P (2006) Nosocomial aspergillosis in outbreak settings. J Hosp Infect 63:246–254
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Gangneux, JP. (2017). Environmental Fungal Risk in Health Facilities. In: Viegas, C., Viegas, S., Gomes, A., Täubel, M., Sabino, R. (eds) Exposure to Microbiological Agents in Indoor and Occupational Environments. Springer, Cham. https://doi.org/10.1007/978-3-319-61688-9_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-61688-9_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-61686-5
Online ISBN: 978-3-319-61688-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)